P. Karukonda

IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell

Joe-Marc Chauvin, H. Zarour, V. Hornung, 2019, Cancer Immunology Research.

Declining brachytherapy utilization for high-risk prostate cancer-Can clinical pathways reverse the trend?

D. Heron, S. Beriwal, D. Ling, 2018, Brachytherapy.

Pharmacologic inhibition of ataxia telangiectasia and Rad3‐related (ATR) in the treatment of head and neck squamous cell carcinoma

Y. Mowery, D. Odhiambo, P. Karukonda, 2021, Molecular carcinogenesis.

Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?

S. Beriwal, J. Kelley, R. Edwards, 2018, International Journal of Radiation Oncology, Biology, Physics.

Standardization of radiation therapy dose for locally advanced non-small cell lung cancer through changes to a lung cancer clinical pathway in a large, integrated comprehensive cancer center network.

D. Heron, S. Beriwal, Z. Horne, 2017, Practical radiation oncology.

ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation

T. Conrads, P. Tran, R. Ferris, 2018, The Journal of clinical investigation.

A Window to Internet-based Information Seeking of US Fourth-Year Medical Students: Are Radiation Oncology Residency Program Websites Comprehensive?

Charles R. Thomas, D. Heron, D. Hansberry, 2018, International journal of radiation oncology, biology, physics.

Pre-operative Radiation and Immunotherapy in the Treatment of Non-metastatic Breast Cancer

S. McDuff, A. Ho, P. Karukonda, 2023, Current Breast Cancer Reports.

Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?

S. Beriwal, J. Kelley, A. Olawaiye, 2018, International journal of radiation oncology, biology, physics.